Franauis Xavier Mauron

François-Xavier Mauron is a Partner in Andera Partners’ Andera MidCap team and was appointed Managing Partner of Andera Partners in February 2025 for a two-year term alongside Stéphane Bergez. Andera describes him as having joined the management company in 2010 and as part of the mid-market team.

Before Andera, Mauron worked in private equity at Activa Capital from 2004 to 2010 as an Investment Director. Andera lists his Activa deal experience across healthcare, distribution, and B2B services, including Vivactis, Delpharm, F.Saget / Linvosges, BFI Optilas, and Ergalis.

Earlier in his career, he worked in mergers and acquisitions at KPMG Corporate Finance in London and Paris from 2000 to 2004. He graduated from HEC Paris in 2000 and has chaired the HEC Alumni Club for M&A and Private Equity since 2015. He speaks French, German, and English.

• Andera MidCap backs growth companies and shareholder-managers pursuing scale-up strategies and organizational transformation.
• The team invests €40m to €120m per company, taking majority or minority stakes in growth capital, OBO/MBO, and carve-out situations.
• Andera MidCap’s stated target is companies with €100m to €250m in revenue in France and neighboring countries.
• The firm pairs capital with transformation support in organization, human capital, internationalization, digitization, external growth, CSR, operational improvement, and financing.
• In the Ayming transaction, Mauron and Aurélie Owona said the company fit Andera MidCap’s strategy because it had “a seasoned and ambitious leadership team” and a “robust, scalable, and diversified business model.”
• In the Auxiga buyout, Mauron and Laurent Tourtois highlighted “an ambitious and outstanding management team,” rare expertise valued by clients, and a resilient market with growth potential.